Ravi Mehrotra

Stock Analyst at UBS

(1.92)

# 2,954

Out of 4,711 analysts

3

Total ratings

50%

Success rate

6.02%

Average return

Main Sectors:

Industrials Healthcare

Top Industries:

Specialty Industrial Machinery Biotechnology

Stocks Rated by Ravi Mehrotra

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	IR Ingersoll Rand	Assumes: Buy	$102 → $124	$92.28	+34.37%	1	Nov 13, 2024
	CRSP CRISPR Therapeutics AG	Downgrades: In-Line	$85 → $52	$40.72	+27.70%	2	Feb 3, 2020

Ingersoll Rand

Nov 13, 2024

Assumes: Buy

Price Target: $102 → $124

Current: $92.28

Upside: +34.37%

CRISPR Therapeutics AG

Feb 3, 2020

Downgrades: In-Line

Price Target: $85 → $52

Current: $40.72

Upside: +27.70%